METRIX AIR
Report
- Report Number
- 1000113657-2017-00358
- Event Type
- Malfunction
- Date Received
- February 22, 2017
- Date of Event
- January 31, 2017
- Report Date
- February 22, 2017
- Manufacturer
- TRIVIDIA HEALTH, INC.
- Product Code
- NBW
- UDI-DI
- 00021292007584
- PMA / PMN Number
- K150052
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- OTHER
Narratives
(B)(4). RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER HAD AN INACCURATE REFERENCE. (B)(4).
CONSUMER REPORTED COMPLAINT FOR HIGH BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM RESULTS OBTAINED OF 200, 184 AND 168 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 120 - 150 MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2017, A BACK TO BACK BLOOD TEST WAS PERFORMED BY THE CUSTOMER FASTING AND PRODUCED TEST RESULTS OF 244 MG/DL USING TRUEMETRIX AIR METER AND 232 MG/DL USING TRUEMETRIX AIR METER. THE PRODUCT IS STORED ACCORDING TO SPECIFICATION. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 02/28/2018 AND OPEN VIAL DATE IS (B)(6) 2016. CUSTOMER STATED THE RESULT OF 373 MG/DL IN THE METER MEMORY WAS OBTAINED BY USING A CONTROL SOLUTION BELONGING TO A DIFFERENT BRAND OF METER. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: (B)(6). MEMORY CONCERNS: THE CUSTOMER IS CONCERNED WITH ALL OF THE READINGS IN THE MEMORY EXCEPT THE 373. THE 373 READING WAS OBTAINED BY USING A CONTROL SOLUTION FOR ANOTHER METER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 133438 | METRIX AIR | BLOOD GLUCOSE SYSTEM | NBW | TRIVIDIA HEALTH, INC. | METRIX AIR | MT1922 | 00021292007584 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 0 YR | SECOND THERAPY |